Back to the Top
The following message was posted to: PharmPK
What determines the choice of analyte with regard to drugs in the
conjugates or circulating free in establishing bioequivalence. There are
instances where you have to do the analysis on the total drug form
than the separate entities (free & conjugate) so I was wondering what
criteria are in this case. Any references discussing this issue?
Thanks a lot
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Conjugated vs unconjugated" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (email@example.com)